Marked Independent Relationship between Circulating Interleukin-6 Concentrations and Endothelial Activation in Rheumatoid Arthritis

Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?

(2013) Patrick H Dessein et al.   ANNALS OF THE RHEUMATIC DISEASES

Independent relationship between circulating resistin concentrations and endothelial activation in rheumatoid arthritis

(2013) Patrick H Dessein et al.   ANNALS OF THE RHEUMATIC DISEASES

Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study

(2013) Alfonso Corrales et al.   ANNALS OF THE RHEUMATIC DISEASES

Multiple Biomarkers for the Prediction of Ischemic Stroke

(2013) Christof Prugger et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Brief Report: Interleukin-6 as an Inflammatory Mediator and Target of Therapy in Chronic Periaortitis

(2013) Augusto Vaglio et al.   ARTHRITIS AND RHEUMATISM

Towards a role of interleukin-32 in atherosclerosis

(2013) Bas Heinhuis et al.   CYTOKINE

Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis

(2013) K. Shimamoto et al.   JOURNAL OF RHEUMATOLOGY

A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis

(2012) Shawn Rose et al.   ANNALS OF THE RHEUMATIC DISEASES

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

(2012) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Toll-Like Receptor 4 Activation in Microvascular Endothelial Cells Triggers a Robust Inflammatory Response and Cross Talk With Mononuclear Cells via Interleukin-6

(2012) Zhongyang Lu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The Carotid Artery Atherosclerosis Burden and Its Relation to Cardiovascular Risk Factors in Black and White Africans with Established Rheumatoid Arthritis: A Cross-sectional Study

(2012) A. SOLOMON et al.   JOURNAL OF RHEUMATOLOGY

Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis

(2012) K. P. Liao et al.   RHEUMATOLOGY

Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study

(2012) Ahmed Solomon et al.   ARTHRITIS RESEARCH & THERAPY

Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis

(2012) Miguel A González-Gay et al.   ARTHRITIS RESEARCH & THERAPY

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

(2011) E. Myasoedova et al.   ANNALS OF THE RHEUMATIC DISEASES

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity

(2010) D. H. Solomon et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk Factor Profiles for Atherosclerotic Cardiovascular Disease in Black and Other Africans with Established Rheumatoid Arthritis

(2010) A. SOLOMON et al.   JOURNAL OF RHEUMATOLOGY

Sex and Ethnic Differences in 47 Candidate Proteomic Markers of Cardiovascular Disease: The Mayo Clinic Proteomic Markers of Arteriosclerosis Study

(2010) Charles X. Kim et al.   PLoS One

Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness

(2010) Anna Södergren et al.   ARTHRITIS RESEARCH & THERAPY

Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor

(2009) M. Hashizume et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

(2009) E Choy et al.   ANNALS OF THE RHEUMATIC DISEASES

Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis

(2009) Young Hee Rho et al.   ARTHRITIS AND RHEUMATISM

Which Are the Determinants of Dyslipidemia in Rheumatoid Arthritis and Does Socioeconomic Status Matter in This Context?

(2009) P. H. DESSEIN et al.   JOURNAL OF RHEUMATOLOGY

Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis

(2008) A Stavropoulos-Kalinoglou et al.   ANNALS OF THE RHEUMATIC DISEASES

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes

(2008) Björn Zethelius et al.   NEW ENGLAND JOURNAL OF MEDICINE

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

(2008) Bevra H Hahn et al.   ARTHRITIS RESEARCH & THERAPY